First Page | Document Content | |
---|---|---|
Date: 2009-04-10 00:14:29COX-2 inhibitors Acetic acids Organochlorides Lumiracoxib Organofluorides Healthcare in Australia Adverse Drug Reactions Advisory Committee Therapeutic Goods Administration Non-steroidal anti-inflammatory drug Chemistry Medicine Health | Add to Reading ListSource URL: www.rheumatology.org.auDownload Document from Source WebsiteFile Size: 104,00 KBShare Document on Facebook |
Microsoft Word - Healthcare_Professional_Letter_19Aug07.docDocID: 13MHh - View Document | |
From: Graham Malouf Sent: Friday, 17 August[removed]:50 PM To: Freya Michie Cc: Tim Palmer Subject: RE: Media Watch inquiry Dear FreyaDocID: XVrM - View Document | |
DOC DocumentDocID: XjqC - View Document | |
Novartis Basic registration templateDocID: ywM3 - View Document | |
ASKATCHEWAN DRUG INFORMATION SERVICE College of Pharmacy and Nutrition y University of Saskatchewan 110 Science Place y Saskatoon SK y S7N 5C9 y www.usask.ca/druginfo Hepatic Concerns with Prexige® (lumiracoxib) AugustDocID: s5f5 - View Document |